MEI Pharma LITS
MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001140361-25-026773
- Document
- 8-K
- Exhibit 1.1
- Underwriting or sales agreement
- Exhibit 4.1
- Warrants or notes
- Exhibit 4.2
- Warrants or notes
- Exhibit 4.3
- Warrants or notes
- Exhibit 4.4
- Warrants or notes
- Exhibit 4.5
- Warrants or notes
- Exhibit 4.6
- Warrants or notes
- Exhibit 10.1
- Material contract
- Exhibit 10.2
- Material contract
- Exhibit 10.3
- Material contract
- Exhibit 10.4
- Material contract
- Exhibit 10.5
- Material contract
- Exhibit 10.6
- Material contract
- Exhibit 10.7
- Material contract
- Exhibit 99.1
- Press release
- Signs a material agreement (1.01)
- Ends a material agreement (1.02)
- Sells unregistered shares (3.02)
- Reports an executive or board change (5.02)
- Discloses other events (8.01)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Actinium Pharmaceuticals ATNM public float $44M, Jun 30, 2025
- Fortress Biotech FBIO public float $44M, Jun 30, 2025
- Actuate Therapeutics ACTU public float $42M, Jun 30, 2025
- Acumen Pharmaceuticals ABOS public float $45M, Jun 30, 2025
- Opus Genetics IRD public float $46M, Jun 30, 2025